|
Peptides
GFR alpha 1 Peptide
Background
GFR alpha 1 (Intermediate Domain) Peptide
Location
14 amino acids near the center of human GFR alpha 1.
Application
GFR alpha 1 peptide is used for blocking the activity of Anti-GFR alpha 1 (Cat. No. 1133). Incubating the peptide with equal volume of antibody for 30 min at 37˚C usually completely blocks the antibody activity in Western blotting.
Tested Application
Bl
Buffer
PBS containing 0.02% sodium azide
Storage
GFR alpha 1 peptide is supplied as 200 μg/ml, 50 μg/vial, in PBS pH7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide. Store at -20˚C, stable for one year.
Species Reactivity
n/a
Species
H
Short Description
(IN) GFR alpha 1 peptide
This product belongs to the following categories:
Related Products
References- Vincenz.C. and Dixit,V.M. Fas-associated death domain protein interleukin-1β-converting enzyme 2 (FLICE2), an ICE/Ced-3 homologue, is proximally involved in CD95- and p55-mediated death signaling. J. Biol. Chem. 1997;272:6578-6583
- Fernandes-Alnemri T, Armstrong RC, Krebs J, Srinivasula SM, Wang L Bullrich F, Fritz LC, Trapani JA, Tomaselli KJ, Litwack G, Alnemri ES. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc. Natl. Acad. Sci. USA. 1996;93:7464-7469
- Cohen GM. Caspases: the executioners of apoptosis. Biochem J 1997;326:1-16 (RD1299)
Datasheet 0801-W
|
|
